In children with suspected IBD, what is the evidence for ASCA and p-ANCA testing to differentiate UC from CD

What is known

- ASCA is associated with Crohn disease and p-ANCA is a recognized marker for ulcerative colitis. ¹ - Combined measurement of pANCA and ASCA has been proposed as a diagnostic approach to differentiate ulcerative colitis from Crohn disease. ^2,3 - The role of pANCA and ASCA in IBD diagnosis and differentiation is described as still imprecise and controversial. ⁴ - Endoscopy, radiology and histopathology remain the basis of diagnosis, and differentiation is not possible in a minority of cases (indeterminate colitis). ⁵

What is unknown / caveats

- Some sources frame combined ASCA/pANCA as a helpful diagnostic tool, while others state its role is imprecise and controversial - Retrieved excerpts are largely background sections and reference lists, without extractable pediatric sensitivity/specificity data - No excerpt directly reports the diagnostic performance of these markers specifically in children with suspected IBD - The excerpts establish the marker–disease associations but do not quantify how reliably combined testing differentiates the two conditions in children.

## References

1. Lecis P, Germanà B, Papa N, Bertiato G, Doglioni C, Galliani E, Biedo FC. [p-ANCA and ASCA antibodies in the differential diagnosis between ulcerative rectocolitis and Crohn's disease]. Recenti Prog Med. 2002;93(5):308-13. PMID: 12050913.

2. Koutroubakis IE, Petinaki E, Mouzas IA, Vlachonikolis IG, Anagnostopoulou E, Castanas E, Maniatis AN, Kouroumalis EA. Anti-Saccharomyces cerevisiae mannan antibodies and antineutrophil cytoplasmic autoantibodies in Greek patients with inflammatory bowel disease. Am J Gastroenterol. 2001;96(2):449-54. PMID: 11232689.

3. Papadakis KA, Targan SR. Serologic testing in inflammatory bowel disease: its value in indeterminate colitis. Curr Gastroenterol Rep. 1999;1(6):482-5. PMID: 10980990.

4. Mokrowiecka A, Daniel P, Słomka M, Majak P, Malecka-Panas E. Clinical utility of serological markers in inflammatory bowel disease. Hepatogastroenterology. 2009;56(89):162-6. PMID: 19453050.

5. Montanelli A, Mainardi E, Vagni A, Villanacci V, Zambelli C, Cestari R, Cengia P, Minelli L, Missale G. Immunological markers anti-saccharomyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: a helpful diagnostic tool. Minerva Gastroenterol Dietol. 2005;51(2):201-7. PMID: 15990710.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

---

_Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct._